TP53BP1 and breast carcinoma: DNA damage measured by 53BP1 in PBMCs isolated from blood of apparently healthy donors (N) and unselected breast cancer (BC) patients after exposure to 0.5 or 2 Gy of X-irradiation in vitro* or after 5 clinical fractions (BC patients)